PLIANT THERAPEUTICS, INC. (PLRX) Operating cash flow 2019–2025
PLIANT THERAPEUTICS, INC. (PLRX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$128.3MFY2025 · since FY2019: -$2.8M → -$128.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$128.3M | +17.5% |
| FY2024 | -$155.5M | -33.6% |
| FY2023 | -$116.4M | -23.0% |
| FY2022 | -$94.6M | -25.4% |
| FY2021 | -$75.4M | -102.4% |
| FY2020 | -$37.3M | -1255.3% |
| FY2019 | -$2.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice